Get a glimpse into our company and investor data—powered by the PitchBook Platform
Blackstone Life Sciences
Blackstone Life Sciences is a segment of the private equity firm, The Blackstone Group. It prefers to invests in companies operating in the life science, pharma, medical device research, biotechnology and healthcare sectors. The firm is a result of The Blackstone Group's acquisition of Clarus Ventures in 2018.